Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Kralupy nad Vltavou

6 clinical trials in Kralupy nad Vltavou, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Kralupy nad Vltavou at a glance
6
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Kralupy nad Vltavou

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Chiesi Farmaceutici S.p.A.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2
  • Sponsor:Upstream Bio Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Genentech Inc.

Asthma

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Azd8630
  • Sponsor:AstraZeneca AB

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Kralupy nad Vltavou

What the registry says about research in the country

01 Respiratory Disease Research

Clinical trials focusing on chronic respiratory conditions, investigating novel therapeutic approaches for patients with challenging respiratory disorders.

  • Uncontrolled Asthma Studies
  • COPD Management Research
  • Exacerbation Prevention

These trials aim to evaluate new treatments for patients with severe respiratory conditions, particularly focusing on reducing exacerbation rates and improving disease control.

02 Treatment Innovation

Groundbreaking research exploring the effectiveness of novel therapeutic agents like AZD8630 and astegolimab in managing respiratory conditions.

  • Drug Safety Assessment
  • Treatment Efficacy Studies
  • Long-term Outcome Analysis

Research focuses on comparing these innovative treatments with placebos to determine their impact on disease management and patient outcomes.

03 Clinical Outcomes

Comprehensive evaluation of treatment effectiveness in respiratory diseases, with particular attention to exacerbation prevention and management.

  • Exacerbation Rate Analysis
  • Disease Control Assessment
  • Patient Response Monitoring

Studies are designed to measure both immediate and long-term treatment effects over extended observation periods of up to 52 weeks.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.